Table 1.
Twelve-month treatment by 12-month DSM-IV/CIDI disorder and perceived need with and without delaysa
| Disorder prevalence | PN/dx | Treatment/PN + | Treatment/PN- | Treatment/total | Treatment without delay/PN + | Treatment with delay/PN + | |
|---|---|---|---|---|---|---|---|
| % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | % (SE) | |
| I. Anxiety disorders | |||||||
| GAD | 13.2 (0.4) | 59.7 (1.5) | 45.8 (2.0) | 6.6 (1.1) | 30.0 (1.4) | 16.4 (1.3) | 29.4 (1.7) |
| Panic/Ago | 11.2 (0.4) | 61.0 (1.5) | 45.9 (1.8) | 8.1 (1.3) | 31.1 (1.4) | 18.1 (1.6) | 27.8 (1.8) |
| PTSD | 9.2 (0.4) | 56.7 (2.1) | 45.1 (2.6) | 5.6 (1.0) | 28.0 (1.8) | 15.5 (1.4) | 29.6 (2.6) |
| SP | 38.3 (0.7) | 33.3 (0.9) | 27.3 (1.2) | 1.6 (0.3) | 10.2 (0.5) | 9.4 (0.8) | 17.9 (1.1) |
| SoP | 16.2 (0.4) | 50.7 (1.4) | 37.1 (1.8) | 3.6 (0.7) | 20.6 (1.1) | 13.1 (1.3) | 23.9 (1.5) |
| Any | 67.6 (0.6) | 40.7 (0.7) | 33.2 (1.0) | 2.5 (0.3) | 15.0 (0.5) | 12.8 (0.7) | 20.4 (0.8) |
| II. Mood disorders | |||||||
| MDD | 31.3 (0.6) | 55.8 (1.0) | 39.1 (1.3) | 5.5 (0.6) | 24.2 (0.9) | 16.8 (0.9) | 22.3 (1.0) |
| BD | 8.4 (0.3) | 56.8 (1.9) | 32.8 (2.2) | 6.5 (1.4) | 21.5 (1.4) | 11.6 (1.6) | 21.2 (1.8) |
| Any | 39.7 (0.6) | 56.0 (0.9) | 37.8 (1.2) | 5.7 (0.5) | 23.7 (0.8) | 15.7 (0.8) | 22.0 (0.9) |
| III. Substance use disorders | |||||||
| AUD | 14.0 (0.5) | 33.8 (1.5) | 23.9 (2.1) | 2.7 (0.7) | 9.8 (0.9) | 7.6 (1.5) | 16.3 (1.7) |
| DUD | 4.1 (0.3) | 46.0 (3.4) | 31.5 (4.4) | 5.9 (1.7) | 17.7 (2.5) | 8.2 (2.4) | 23.3 (3.5) |
| Any | 16.8 (0.5) | 34.7 (1.5) | 25.2 (2.0) | 3.0 (0.6) | 10.7 (1.0) | 8.0 (1.3) | 17.2 (1.6) |
| IV. Disorder severity | |||||||
| Severe | 27.3 (0.6) | 58.7 (1.1) | 39.6 (1.4) | 7.6 (0.8) | 26.4 (1.0) | 16.1 (0.9) | 23.5 (1.1) |
| Moderate | 38.6 (0.6) | 41.9 (1.0) | 28.2 (1.3) | 2.1 (0.3) | 13.0 (0.6) | 11.3 (0.9) | 16.9 (1.1) |
| Mild | 34.1 (0.6) | 25.1 (0.9) | 18.1 (1.5) | 0.6 (0.2) | 5.0 (0.4) | 8.6 (1.0) | 9.5 (1.0) |
| V. Any disorderb | 100.0 (-) | 40.7 (0.6) | 30.6 (0.8) | 2.5 (0.2) | 13.9 (0.4) | 12.6 (0.5) | 17.9 (0.6) |
| (n) | (11,622) | (11,622) | (5,136) | (6,486) | (11,622) | (5,136) | (5,136) |
DSM-IV/CIDI disorders disorders assessed with the Composite International Diagnostic Interview (CIDI) based on DSM-IV criteria, PN/dx Perceived Need for treatment in the row diagnosis, Treatment/PN + Treatment among respondents with perceived need, Treatment/PN- Treatment among respondents without perceived need, Treatment/Total Treatment in the total sample, Treatment without delay/PN + Treatment without delay given perceived need, TC with delay/PN + Treatment with delay given perceived need, % proportion of observation in the column total with the heading, SE the design-based standard error of % taking into consideration weighting and geographic clustering of observations, GAD generalized anxiety disorder, Panic/Ago Panic disorder or agoraphobia, PTSD post-traumatic stress disorder, SP specific phobia, SoP social phobia, MDD major depressive disorder, BD bipolar spectrum disorder, AUD alcohol use disorder (either misuse or dependence), DUD drug use disorder (either misuse or dependence), Severe the subset of respondents with either 12-month BP-I, AUD with a physiological dependence syndrome, DUD with a physiological dependence syndrome, suicide attempt, of self-reported severe role impairment due to their 12-month mental and/or substance use disorders; Moderate, the subset of respondents without moderate role impairment, Mild the subset of respondents with mild role impairment; (n), the unweighted number of survey observations in the denominator, either the total sample of respondents with a 12-month disorder (n = 11,622), the subsample of such respondents with perceived need (n = 5,136), or the subsample without perceived need (n = 6,486). Note that the observed proportion of respondents with perceived need (i.e., 5,136/11,622 = 44.2%) is higher than the 40.7% reported in the last row of the PN/dx column due to weighted data being used in analysis
aPooled across all WMH surveys, with surveys weighted by sample size rather than by country population size
bOverall prevalence of any 12-month disorder in the total sample, considering all countries included, is 14.2%